Health-related quality of life in hemato-oncology patients: role of informativeness and doctor-patient communication
Background
The patient’s information about the disease and doctor-patient communication are both constructs whose importance is emphasized in the theory, but much less frequently researched and used in the practice.
Objective
This study aimed to determine whether certain facets of health-related quality of life of hemato-oncology patients in Croatia could be predicted based on patients’ sociodemographic data, the disease’s determinants, the patients’ information about their disease and the quality of doctor-patient communication.
Methods
60 women and 54 men with diagnoses of both leukemia and lymphoma have participated in filling out questionnaires. The survey consisted of a sociodemographic questionnaire, EORTC QLQ-C30~(version 3)~, EORTC QLQ-INFO25 and the Doctor-Patient Communication Questionnaire.
Results
Patients’ sociodemographic data, the disease’s determinants, the patients’ information about their disease and the quality of doctor-patient communication predicted 26.8 % variance of global health status (F = 2.756, p < .01), 35.7% variance of physical functioning (F = 4.196, p < .01), 23.3% variance of role functioning (F = 2.291, p < .05), 29.9% variance of emotional functioning (F = 3.215, p < .01) and 27.9% of social functioning (F = 2.881, p < .01). Predictors that significantly contributed to the change in variance of health-related quality of life were age, duration of diagnosis, the existence of comorbidity, frequency of hospitalization, talking with the psychologist after getting the diagnosis and information.
Conclusion
The study offers valuable insights into an under-researched patient population and a better understanding of their health-related quality of life. The results indicate the importance of information that can be implemented in everyday clinical practice, and pave the way for further research on doctor-patient communication.
1. Mughal TI, Goldman JM, Mughal ST. Understanding Leukemias, Lymphomas and Myelomas. Informa Healthcare; 2006. doi:10.1201/b13878
2. Hoskin P. Clinical Oncology: Basic Principles and Practice. 5th ed. CRC Press; 2020. doi:10.1201/9781315267081
3. Krieger T, Salm S, Dresen A, Cecon N. Cancer patients’ experiences and preferences when receiving bad news: a qualitative study. Journal of cancer research and clinical oncology. 2023;149(7):3859-3870. doi:10.1007/s00432-022-04311-8
4. von Knorring J, Lehti A, Fahlström M, Semb O. Empathy as a silent art-A doctor´s daily balancing act: A qualitative study of senior doctors’ experiences of empathy. PloS one. 2022;17(12):e0277474. doi:10.1371/journal.pone.0277474
5. Bartholomäus M, Zomorodbakhsch B, Micke O, et al. Cancer patients’ needs for virtues and physicians’ characteristics in physician-patient communication: a survey among patient representatives. Support Care Cancer. 2019;27(8):2783-2788. doi:10.1007/s00520-018-4585-3
6. Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner journal. 2010;10(1):38-43.
7. Little P, Everitt H, Williamson I, et al. Preferences of patients for patient centred approach to consultation in primary care: observational study. The BMJ. 2001;322(7284):1-7. doi:10.1136/bmj.322.7284.468
8. Kissane DW, Bultz BD, Butow PN, Bylund CL, Noble S, Wilkinson S. Oxford Textbook of Communication in Oncology and Palliative Care. 2nd ed. Oxford University Press; 2017. doi:10.1093/med/9780198736134.001.0001
9. Sustersic M, Gauchet A, Kernou A, et al. A scale assessing doctor-patient communication in a context of acute conditions based on a systematic review. PLoS One. 2018;13(2):1-16. doi:10.1371/journal.pone.0192306
10. Morelli E, Mulas O, Caocci G. Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clinical Practice and Epidemiology in Mental Health: CP & EMH. 2021;17(1):264-270. doi:10.2174/1745017902117010264
11. Aoun A, Al Hayek S, El Jabbour F. The need for a new model of the physician–patient relationship: a challenge for modern medical practice. Family Medicine & Primary Care Review. 2018;20(4):379-384. doi:10.5114/fmpcr.2018.79351
12. Vučemilo L, Ćurković M, Milošević M, Mustajbegović J, Borovečki A. Are physician-patient communication practices slowly changing in Croatia? – a cross-sectional questionnaire study. Croatian Medical Journal. 2013;54(2):185-191. doi:10.3325/cmj.2013.54.185
13. Skär L, Söderberg S. Patients’ complaints regarding healthcare encounters and communication. Nursing open. 2018;5(2):224-232. doi:10.1002/nop2.132
14. Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L. Information needs and experiences: An audit of UK cancer patients. European Journal of Oncology Nursing. 2006;10(4):263-272. doi:10.1016/j.ejon.2005.10.007
15. Arraras JI, Greimel E, Sezer O, et al. An international validation study of the EORTC QLQ-INFO25 questionnaire: An instrument to assess the information given to cancer patients. European Journal of Cancer. 2010;46(15):2726-2738. doi:10.1016/j.ejca.2010.06.118
16. Maguire P. Improving communication with cancer patients. European Journal of cancer. 1999;35(14):2058-2065. doi:10.1016/s0959-8049(99)00301-9
17. Davies N, Kinman G, Thomas RJ, Bailey T. Information satisfaction in breast and prostate cancer patients: implications for quality of life. Psycho-Oncology. 2008;17(10):1048-1052. doi:10.1002/pon.1305
18. Tabchi S, El Rassy E, Khazaka A, et al. Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss? Quality of life research. 2016;25(6):1597-1604. doi:10.1007/s11136-015-1201-6
19. Ector GI, Verweij L, Hermens RP, Blijlevens NM. Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife. Patient Education and Counseling. 2022;105(3):686-694. doi:10.1016/j.pec.2021.06.025
20. Weinman J, Yusuf G, Berks R, Rayner S, Petrie KJ. How accurate is patients’ anatomical knowledge: a cross-sectional, questionnaire study of six patient groups and a general public sample. BMC Family Practice. 2009;10(1):1-6. doi:10.1186/1471-2296-10-43
21. Weeks JC, Catalano PJ, Cronin A, et al. Patients’ expectations about effects of chemotherapy for advanced cancer. New England Journal of Medicine. 2012;367(17):1616-1625. doi:10.1056/NEJMoa1204410
22. Soylu C, Babacan T, Sever AR, Altundag K. Patients’ understanding of treatment goals and disease course and their relationship with optimism, hope, and quality of life: a preliminary study among advanced breast cancer outpatients before receiving palliative treatment. Supportive Care in Cancer. 2016;24:3481-3488. doi:10.1007/s00520-016-3182-6
23. Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot DC, Fallowfield LJ. What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. J Clin Oncol. 2011;29(1):61-68. doi:10.1200/JCO.2010.30.0814
24. Karimi M, Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? PharmacoEconomics. 2016;34(7):645-649. doi:10.1007/s40273-016-0389-9
25. Zheng S, He A, Yu Y, Jiang L, Liang J, Wang P. Research trends and hotspots of health-related quality of life: a bibliometric analysis from 2000 to 2019. Health Qual Life Outcomes. 2021;19(1):130. doi:10.1186/s12955-021-01767-z
26. European Organisation For Research And Treatment Of Cancer. Quality of Life Group Website. Accessed June 21, 2023. https://qol.eortc.org/
27. Van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Quality of life and non-pain symptoms in patients with Cancer. Journal of Pain and Symptom Management. 2009;38(2):216-233. doi:10.1016/j.jpainsymman.2008.08.014
28. Pulgar A, Alcala A, Reyes del Paso GA. Psychosocial predictors of quality of life in hematological cancer. Behavioral Medicine. 2015;41(1):1-8. doi:10.1080/08964289.2013.833083
29. Ledinski Fičko S, Čukljek S, Hošnjak AM, Smrekar M, Kurtović B, Kovačević I. Čimbenici utjecaja na kvalitetu života hematoloških Medicinskih Sestara i Tehničara. ; 2021:5-6.
30. Niscola P, Tendas A, Scaramucci L, et al. Pain in malignant hematology. Expert Review of Hematology. 2011;4(1):81-93. doi:10.1586/ehm.10.79
31. Samouh Y, Kbirou A, Sbai Othmani I, Derfoufi S, Benmoussa A. Depression and anxiety in hematological cancer patient: Prevalence and associated factors. Annales Medico-Psychologiques. 2021;180(8):1-5. doi:10.1016/j.amp.2021.03.023
32. Ellehuus C, Jeppesen SS, Eckhoff L, et al. Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations–a Danish single site cross-sectional survey. Acta Oncologica. 2021;60(7):872-880. doi:10.1080/0284186X.2021.1902565
33. Fadul NA, Osta BE, Dalal S, Poulter VA, Bruera E. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. Journal of palliative medicine. 2008;11(3):422-427. doi:10.1089/jpm.2007.0184
34. Hochman MJ, Yu Y, Wolf SP, Samsa GP, Kamal AH, LeBlanc TW. Comparing the palliative care needs of patients with hematologic and solid malignancies. Journal of Pain and Symptom Management. 2018;55(1):82-88. doi:10.1016/j.painsymman.2017.08.030
35. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in International clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365-376. doi:10.1093/jnci/85.5.365
36. Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 Scoring Manual. 3rd ed. European Organisation for Research and Treatment of Cancer; 2001.
37. Giesinger JM, Loth FL, Aaronson NK, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. Journal of clinical epidemiology. 2020;118:1-8. doi:10.1016/j.jclinepi.2019.10.003
38. Bellali T, Manomenidis G, Meramveliotaki E, Minasidou E, Galanis P. The impact of anxiety and depression in the quality of life and psychological well-being of Greek hematological cancer patients on chemotherapy. Psychology, Health and Medicine. 2019;25(8):1-13. doi:10.1080/13548506.2019.1695864
39. Guirimand F, Buyck JF, Lauwers-Allot E, et al. Cancer-related symptom assessment in France: Validation of the French M. D. Anderson Symptom Inventory. Journal of Pain and Symptom Management. 2010;39(4):721-733. doi:10.1016/j.jpainsymman.2009.08.014
40. Efficace F, Gaidano G, Lo-Coco F. Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood. 2017;130(7):859-866. doi:10.1182/blood-2017-03-737403
41. Westman B, Ullgren H, Olofsson A, Sharp L. Patient-reported perceptions of care after the introduction of a new advanced cancer nursing role in Sweden. European Journal of Oncology Nursing. 2019;41:41-48. doi:10.1016/j.ejon.2019.05.009
42. Fritzsche K, Struss Y, Stein B, Spahn C. Psychosomatic liaison service in hematological oncology: need for psychotherapeutic interventions and their realization. Hematological oncology. 2003;21(2):83-89. doi:10.1002/hon.711
43. Statham C, Davis C. Psychological burden of haematological cancer on patient and family. Is it time for multisystem approach? Current Opinion in Supportive and Palliative Care. 2018;12(4):518-521. doi:10.1097/SPC.0000000000000396
44. Meier C, Taubenheim S, Lordick F, Mehnert-Theuerkauf A, Götze H. Depression and anxiety in older patients with hematological cancer (70+)–Geriatric, social, cancer-and treatment-related associations. Journal of Geriatric Oncology. 2020;11(5):828-835. doi:10.1016/j.jgo.2019.11.009
45. Zysberg L, Hai S, Dally N. A new take on a resource-based model of quality of life in hemato-oncological patients: Demographic, personal, and social factors. Journal of Clinical Psychology in Medical Settings. 2019;26(4):430-439. doi:10.1007/s10880-019-09600-y